微创与标准体外循环在主动脉瓣手术中的随机试验
该随机对照试验纳入128例择期孤立主动脉瓣置换成人患者,比较微创体外循环(MiECC)与标准体外循环对术后失血的影响。主要终点为术后12小时及拔管时失血量。结果显示MiECC组12小时失血量显著低于标准组,且血红蛋白水平保持更好,但早期临床结局和长期生存无差异。
要点
- MiECC组术后12小时失血量显著低于标准体外循环组。
- MiECC组术后1小时和12小时血红蛋白水平保持更好。
- 两组早期临床结局和长期生存无差异。
核心结论
- 在择期孤立主动脉瓣置换术中,使用MiECC在短期和长期随访中关于失血方面临床等效。
研究设计与样本
- 随机临床试验,纳入128例择期孤立主动脉瓣置换成人患者,排除既往心脏手术和既存肾衰竭者。
主要发现
- MiECC组(n=63)术后12小时失血量230 mL(95%CI 203-261 mL),标准组(n=62)为288 mL(95%CI 241-344 mL),p=0.04。
- MiECC组术后1小时和12小时血红蛋白水平保持(p<0.001)。
- 早期临床结局和长期生存无差异。
临床怎么用
- 对于择期孤立主动脉瓣置换患者,MiECC可减少术后12小时失血并更好保持血红蛋白水平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Complications related to extracorporeal circulation remain serious. Although a minimal invasive extra corporeal circulation (MiECC) system was developed to cope with these complications, its effectivity on patient-related outcomes such as blood loss remain uncertain. Therefore, the aim of this study is to compare MiECC to an advanced standard system with respect to blood loss. METHODS: A total of 128 adult patients undergoing elective isolated aortic valve replacement were enrolled in a randomized clinical trial. Patients who had undergone previous heart surgery and with preexisting kidney failure were excluded. The primary end point was postoperative blood loss after 12 hours and at drain removal. Secondary end points included intensive care and total length of stay and intubation time. At 1 hour and 12 hours after surgery, clinical laboratory data were determined. Early clinical outcomes and long-term survival were determined. RESULTS: MiECC patients (n = 63) had a significant lower blood loss (230 mL, 95% confidence interval: 203 to 261 mL) than regular patients (n = 62) after 12 hours (288 mL, 95% confidence interval: 241 to 344 mL, p = 0.04). A preservation of hemoglobin levels 1 hour and 12 hours after surgery in the MiECC group were observed (p < 0.001). No difference was found in early clinical outcomes and long-term survival. CONCLUSIONS: This randomized controlled trial compares MiECC and an advanced system for aortic valve replacement with blood loss as primary end point. We conclude that using MiECC is clinically equal for short- and long-term follow-up regarding blood loss. CLINICAL TRIAL REGISTRATION: NTR3378.
引用
- Halfwerk FR, Knol K, Mariani S, et al. Randomized Trial of Miniaturized Versus Standard Extracorporeal Circulation in Aortic Valve Surgery. Ann Thorac Surg. 2019. PMID: 30771329. doi:10.1016/j.athoracsur.2019.01.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。